405 related articles for article (PubMed ID: 26477039)
1. Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.
Ultsch B; Damm O; Beutels P; Bilcke J; Brüggenjürgen B; Gerber-Grote A; Greiner W; Hanquet G; Hutubessy R; Jit M; Knol M; von Kries R; Kuhlmann A; Levy-Bruhl D; Perleth M; Postma M; Salo H; Siebert U; Wasem J; Wichmann O
Pharmacoeconomics; 2016 Mar; 34(3):227-44. PubMed ID: 26477039
[TBL] [Abstract][Full Text] [Related]
2. Barriers to generalizability of health economic evaluations in Latin America and the Caribbean region.
Augustovski F; Iglesias C; Manca A; Drummond M; Rubinstein A; Martí SG
Pharmacoeconomics; 2009; 27(11):919-29. PubMed ID: 19888792
[TBL] [Abstract][Full Text] [Related]
3. A guideline for economic evaluations of vaccines and immunization programs in China.
Fang H; Chen C; Fang Y; He X; Hou Z; Jiang M; Jiang Y; Li S; Liu Y; Sui B; Sun Q; Wu J; Xu T; Yang J; Yin Z; Ying X; Yuan B; Zheng H; Zheng Y
Hum Vaccin Immunother; 2022 Nov; 18(6):2132802. PubMed ID: 36287462
[TBL] [Abstract][Full Text] [Related]
4. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of vaccines in Canada: A systematic review.
Chit A; Lee JK; Shim M; Nguyen VH; Grootendorst P; Wu J; Van Exan R; Langley JM
Hum Vaccin Immunother; 2016 May; 12(5):1257-64. PubMed ID: 26890128
[TBL] [Abstract][Full Text] [Related]
6. Who Conducts Health Economic Evaluations of Laboratory Tests? A Scoping Review.
Giusepi I; John AS; Jülicher P
J Appl Lab Med; 2020 Sep; 5(5):954-966. PubMed ID: 32916710
[TBL] [Abstract][Full Text] [Related]
7. Health economic research on vaccinations and immunisation practices--an introductory primer.
Szucs TD
Vaccine; 2005 Mar; 23(17-18):2095-103. PubMed ID: 15755578
[TBL] [Abstract][Full Text] [Related]
8. Systematic Review of Health Economic Impact Evaluations of Risk Prediction Models: Stop Developing, Start Evaluating.
van Giessen A; Peters J; Wilcher B; Hyde C; Moons C; de Wit A; Koffijberg E
Value Health; 2017 Apr; 20(4):718-726. PubMed ID: 28408017
[TBL] [Abstract][Full Text] [Related]
9. Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible?
Jit M; Hutubessy R
Appl Health Econ Health Policy; 2016 Jun; 14(3):245-52. PubMed ID: 26832145
[TBL] [Abstract][Full Text] [Related]
10. National decision-making for the introduction of new vaccines: A systematic review, 2010-2020.
Donadel M; Panero MS; Ametewee L; Shefer AM
Vaccine; 2021 Apr; 39(14):1897-1909. PubMed ID: 33750592
[TBL] [Abstract][Full Text] [Related]
11. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
12. Informing vaccine decision-making: A strategic multi-attribute ranking tool for vaccines-SMART Vaccines 2.0.
Knobler S; Bok K; Gellin B
Vaccine; 2017 Jan; 35 Suppl 1():A43-A45. PubMed ID: 28017435
[TBL] [Abstract][Full Text] [Related]
13. Methodological concerns with economic evaluations of meningococcal vaccines.
Kauf TL
Pharmacoeconomics; 2010; 28(6):449-61. PubMed ID: 20465314
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of meningococcal vaccines: considerations for the future.
Christensen H; Al-Janabi H; Levy P; Postma MJ; Bloom DE; Landa P; Damm O; Salisbury DM; Diez-Domingo J; Towse AK; Lorgelly PK; Shah KK; Hernandez-Villafuerte K; Smith V; Glennie L; Wright C; York L; Farkouh R
Eur J Health Econ; 2020 Mar; 21(2):297-309. PubMed ID: 31754924
[TBL] [Abstract][Full Text] [Related]
15. Stakeholders' perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study.
van der Putten IM; Evers SM; Deogaonkar R; Jit M; Hutubessy RC
BMC Public Health; 2015 Apr; 15():356. PubMed ID: 25881178
[TBL] [Abstract][Full Text] [Related]
16. National Advisory Groups and their role in immunization policy-making processes in European countries.
Nohynek H; Wichmann O; D Ancona F;
Clin Microbiol Infect; 2013 Dec; 19(12):1096-105. PubMed ID: 23957860
[TBL] [Abstract][Full Text] [Related]
17. Systematic Review of Health Economic Evaluation Studies Developed in Brazil from 1980 to 2013.
Decimoni TC; Leandro R; Rozman LM; Craig D; Iglesias CP; Novaes HMD; de Soárez PC
Front Public Health; 2018; 6():52. PubMed ID: 29541630
[TBL] [Abstract][Full Text] [Related]
18. Decision support in vaccination policies.
Piso B; Wild C
Vaccine; 2009 Oct; 27(43):5923-8. PubMed ID: 19698809
[TBL] [Abstract][Full Text] [Related]
19. Incorporating economic evaluation into immunization decision making in Canada: a workshop.
Langley JM; Krahn M; Husereau D; Spika J; Fisman DN; Chit A; Van Exan R
Expert Rev Vaccines; 2014 Nov; 13(11):1291-6. PubMed ID: 25052459
[No Abstract] [Full Text] [Related]
20. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.
Isaacman DJ; Strutton DR; Kalpas EA; Horowicz-Mehler N; Stern LS; Casciano R; Ciuryla V
Clin Ther; 2008 Feb; 30(2):341-57. PubMed ID: 18343273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
